Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Melo

Showing results (91-100 of 330) with videos related to

Pageof 33
Sort By:
Pathology|January 1, 1988
B prolymphocytic leukemia cell lines: phenotype and response to B cell differentiation factorH Zola, V Furness, A Nikoloutsopoulos, et al.
Blood|June 4, 2005
Analysis of total phosphotyrosine levels in CD34+ cells from CML patients to predict the response to imatinib mesylate treatmentBeate Schultheis, Richard Szydlo, François X Mahon, et al.
Haematologica|December 8, 2011
Chronic myeloid leukemia: the basis of treatment for tomorrowAngelo M Carella, John M Goldman, Giovanni Martinelli, et al.
Revista Da Associacao Medica Brasileira (1992)|July 1, 1993
[Suppurative thyroiditis with fatal course in diabetics]J A Nunes Júnior, P G Matos, F V Melo, et al.
Biochimica Et Biophysica Acta|June 1, 1971
Uranyl salts as fixatives for electron microscopy. Study of the membrane ultrastructure and phospholipid loss in bacilliM T Silva, J M Santos Mota, J V Melo, et al.
Leukemia|January 26, 2007
Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell linesD J Barnes, S De, P van Hensbergen, et al.
Virology|December 29, 1999
Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell lineE Garrett, A R Miller, J M Goldman, et al.
Cancer Research|October 3, 2003
Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycinChi Ly, Adrian F Arechiga, Junia V Melo, et al.
Blood|December 12, 2001
Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cellsA J Tipping, F X Mahon, V Lagarde, et al.
British Journal of Haematology|May 20, 2003
Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABLJulian Topaly, Moritz Schad, Stephanie Laufs, et al.
Pageof 33

Showing results (91-100 of 330) with videos related to

Sort By:
Pageof 33
Pathology|January 1, 1988
B prolymphocytic leukemia cell lines: phenotype and response to B cell differentiation factorH Zola, V Furness, A Nikoloutsopoulos, et al.
Blood|June 4, 2005
Analysis of total phosphotyrosine levels in CD34+ cells from CML patients to predict the response to imatinib mesylate treatmentBeate Schultheis, Richard Szydlo, François X Mahon, et al.
Haematologica|December 8, 2011
Chronic myeloid leukemia: the basis of treatment for tomorrowAngelo M Carella, John M Goldman, Giovanni Martinelli, et al.
Revista Da Associacao Medica Brasileira (1992)|July 1, 1993
[Suppurative thyroiditis with fatal course in diabetics]J A Nunes Júnior, P G Matos, F V Melo, et al.
Biochimica Et Biophysica Acta|June 1, 1971
Uranyl salts as fixatives for electron microscopy. Study of the membrane ultrastructure and phospholipid loss in bacilliM T Silva, J M Santos Mota, J V Melo, et al.
Leukemia|January 26, 2007
Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell linesD J Barnes, S De, P van Hensbergen, et al.
Virology|December 29, 1999
Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell lineE Garrett, A R Miller, J M Goldman, et al.
Cancer Research|October 3, 2003
Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycinChi Ly, Adrian F Arechiga, Junia V Melo, et al.
Blood|December 12, 2001
Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cellsA J Tipping, F X Mahon, V Lagarde, et al.
British Journal of Haematology|May 20, 2003
Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABLJulian Topaly, Moritz Schad, Stephanie Laufs, et al.
Pageof 33